Filing Flows

Filing Flows › Thermo Fisher Scientific (TMO) › Q1 2025

Thermo Fisher Scientific (TMO) Q1 2025 earnings results (first quarter 2025)

10-Q filed May 2, 2025

Thermo Fisher Scientific (TMO) reported revenue of $10.4B for the first quarter 2025 (Q1 2025), +0.2% from a year earlier and -9% from the quarter before. Operating margin was 16.6%, net earnings $1.5B (14.6% of revenue).

Revenue$10.4B
Year over year+0.2%
Quarter over quarter-9%
Operating margin16.6%
Net earnings$1.5B

Thermo Fisher Scientific, Q1 2025: revenue $10.4B (+0.2% year over year), operating margin 16.6%, net earnings $1.5B, operating cash flow $723M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$10.4B-9%+0.2%
Operating profit$1.7B-15%+3%
Net earnings$1.5B-17%+14%
Operating cash flow$723M-78%-42%
Free cash flow$361M-87%-60%

What changed

Revenue was $10.4B in Q1 2025, roughly flat year over year and down 9% from the previous quarter. Laboratory Products and Biopharma Services was the largest line at 54% of revenue. Analytical Instruments added $0.05B year over year (up 3%), 253% of the total change. Laboratory Products and Biopharma Services declined 1%.

Operating profit was $1.7B, a 16.6% margin (up 0.5 points year over year). Of the extra revenue versus a year earlier, 279% reached operating profit, above the 16% margin then. Total costs fell 0% while revenue was flat. Net earnings were $1.5B, up 13% year over year. The effective tax rate was 5.9%.

Operating cash flow was $0.72B (down 42% year over year), 48% of net earnings. Non-cash charges added back $0.70B of depreciation and amortization and $0.07B of share-based compensation. Working capital and other items used $1.6B. Capital expenditures of $0.36B left free cash flow of $0.36B.

Questions

What was Thermo Fisher Scientific's revenue in the first quarter 2025?

Thermo Fisher Scientific (TMO) reported revenue of $10.4B for the first quarter 2025 (Q1 2025), +0.2% from a year earlier and -9% from the quarter before.

Was Thermo Fisher Scientific profitable in the first quarter 2025?

Operating profit was $1.7B (16.6% of revenue) and net earnings $1.5B.

Open the interactive Sankey →

Source: Thermo Fisher Scientific 10-Q on SEC EDGAR.